Mersana Therapeutics, Inc. Debt Instrument, Unamortized Premium
Mersana Therapeutics, Inc. had Debt Instrument, Unamortized Premium of $800.00 thousand as of 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Notes › Debt › Debt Instrument, Unamortized Discount (Premium), Net
us-gaap:DebtInstrumentUnamortizedPremium · last filed 2025-08-13
- 2025-06-30: Debt Instrument, Unamortized Premium $800.00K.
- 2025-03-31: Debt Instrument, Unamortized Premium $738.00K.
- 2024-12-31: Debt Instrument, Unamortized Premium $684.00K.
- 2024-09-30: Debt Instrument, Unamortized Premium $630.00K.
| Period end | Debt Instrument, Unamortized Premium |
|---|---|
| 2025-06-30 | $800.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $738.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $684.00K 10-K · filed 2025-03-03 |
| 2024-09-30 | $630.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $576.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $522.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $468.00K 10-K · filed 2024-02-28 |
| 2023-09-30 | $414.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $360.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $306.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $253.00K 10-K · filed 2023-02-28 |
| 2022-09-30 | $198.00K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $144.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $90.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $36.00K 10-K · filed 2022-02-28 |
| 2021-09-30 | $74.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $57.00K 10-Q · filed 2021-08-06 |
| 2021-03-31 | $39.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $23.00K 10-K · filed 2021-02-26 |
| 2020-09-30 | $6.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $78.00K 10-Q · filed 2020-08-07 |
| 2020-03-31 | $62.00K 10-Q · filed 2020-05-08 |
| 2019-12-31 | $45.00K 10-K · filed 2020-02-28 |
| 2019-09-30 | $28.00K 10-Q · filed 2019-11-06 |
| 2019-06-30 | $11.00K 10-Q · filed 2019-08-08 |